TABLE 1

Recommended regimens for Helicobacter pylori

Susceptibility-based, for patients with no drug allergies
Clarithromycin triple therapy
(For infections susceptible to clarithromycin)
All of the following twice daily for 14 days:
 Clarithromycin 500 mg
 Amoxicillin 1 g
 A proton pump inhibitor a
Metronidazole triple therapy
(For infections susceptible to metronidazole)
All of the following twice daily for 14 days:
 Tinidazole 500 mg or metronidazole 500 mg
 Amoxicillin 1 g
 A proton pump inhibitor a
Fluoroquinolone triple therapy
(For infections susceptible to fluoroquinolones)
All of the following for 14 days:
 A fluoroquinolone (eg, levofloxacin 500 mg once daily)
 Amoxicillin 1 g twice a day
 A proton pump inhibitor twice a daya
Susceptibility-based, for patients allergic to penicillin
Bazzoli’s triple therapy
(For infections susceptible to clarithromycin and metronidazole)
All of the following twice daily for 14 days:
 Clarithromycin 500 mg
 Tinidazole 500 mg or metronidazole 500 mg
 A proton pump inhibitor a
Bismuth quadruple therapy
(For infections resistant to clarithromycin or metronidazole)
All of the following for 14 days:
 Bismuth subcitrate or subsalicylate 2 tablets 4 times daily with meals and at bedtime
 Tetracycline hydrochloride 500 mg 4 times daily with meals and at bedtime
 Metronidazole or tinidazole 500 mg 3 times daily with meals
 A proton pump inhibitor twice a day a
  • These therapies are expected to achieve > 90% (often > 95%) cure rates with susceptible infections and adherent patients

  • a Preferred proton pump inhibitors are omeprazole 40 mg, lansoprazole 45 or 60 mg, rabeprazole 20 mg, or esomeprazole 20 mg; pantoprazole is not recommended as 40 mg is approximately equivalent to 9 mg omeprazole.